Skip to main content

Our clinical operations team has gained experience from more than 150 studies of topical and systemic compounds.

Designs for evaluation of safety

Designs for evaluation of safety include:

  • Acute and cumulative cutaneous irritation (21-day cumulative irritation test)
  • Investigation of the sensitization potential (HRIPT)
  • Phototoxicity and photosensitization
  • Skin penetration (Raman)
  • Ocular tolerability
  • Oral tolerability
  • Gynecological tolerability

Designs for proof of concept and efficacy

Designs for proof of concept and efficacy include:

  • Psoriasis plaque test (modified Dumas Scholz)
  • Anti-inflammatory potency (UV-induced erythema model, diphenylcyclopropenone (DPCP-sensitization model))
  • UV-induced Herpes simplex labialis model
  • Burn-induced pain model (topical analgesics)
  • Vasoconstrictor assay (skin Blanching)
  • Superficial wound healing (abrasive wound model, suction blister, laser wounds)
  • Efficacy studies in therapeutic areas
  • Anti-itch models (Cowhage, histamine, mosquito itch)
  • Antiperspirant hotroom test
  • Saliva production (salivary flow and viscosity)
  • Antibacterial efficacy (expanded flora test)